Eupraxia Pharmaceuticals (EPRX)

• Market cap: $317M
• 1 day: 0.64%
• 5 days: 0.32%
• 1 month: -4.7%
• 3 months: 16.91%
• 6 months: 47.31%
• Year to date: 100.96%
• 1 year: 90.61%
• 5 years: 113.22%
• 10 years: 113.22%
• Sector: Healthcare
• Industry: Biotechnology

About: Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

Employees: 33